Cannabis stocks soar as other stocks tumble thumbnail

Cannabis stocks soar as other stocks tumble

CNBC’s Jane Wells takes a look at why cannabis stocks are faring better than much of the market. Steven DeAngelo has seen it all. As the so-called “father of the…

Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC thumbnail

Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC

It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…

ETF Spotlight: Aurora cannabis hit by pandemic-related restrictions thumbnail

ETF Spotlight: Aurora cannabis hit by pandemic-related restrictions

CNBC’s Morgan Brennan takes a look at cannabis-focused ETFs and the dip in Aurora shares. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Subscribe to…

Cannabis stocks in 2022: Top trends for investors to watch thumbnail

Cannabis stocks in 2022: Top trends for investors to watch

Amplify Seymour Cannabis ETF (CNBS) portfolio manager Tim Seymour walks investors through the top trends to watch in the marijuana space in 2022 and beyond. For access to live and…

U.S. vs. Canadian cannabis stocks: Key distinctions thumbnail

U.S. vs. Canadian cannabis stocks: Key distinctions

Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…

Canopy Growth CEO on cannabis sell-off thumbnail

Canopy Growth CEO on cannabis sell-off

Bruce Linton, Canopy Growth CEO, discusses the volatile moves in cannabis stocks just a week after Canada legalized recreational marijuana use.

Amount of cannabis seized at UK airports triples in less than year thumbnail

Amount of cannabis seized at UK airports triples in less than year

The amount of cannabis seized at airports in suitcases has tripled in less than a year, officials have said. The National Crime Agency has said the surge is being driven…

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC thumbnail

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC

Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…

How midterm elections could impact the cannabis business thumbnail

How midterm elections could impact the cannabis business

Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…

Cannabis stocks bounce with legalization in focus — What Tim Seymour's watching thumbnail

Cannabis stocks bounce with legalization in focus — What Tim Seymour’s watching

Tim Seymour, portfolio manager of the Amplify Seymour Cannabis ETF (CNBS) and a CNBC contributor, breaks down what to watch after a huge comeback in cannabis stocks. For access to…